SALT LAKE CITY, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that its Prolaris prostate cancer prognostic ...
A new web-based tool utilizing AI can help pathologists detect prostate cancer faster, say Northeastern University researchers who developed the technology. Prostate cancer is the most common cancer ...
Don't miss out on the headlines from QLD News. Followed categories will be added to My News. The prostate specific antigen test, or PSA test, screens for elevated levels of a protein in a man’s blood ...
Researcher in lab An AI tool outperformed NCCN guidelines for predicting biochemical failure, distant metastasis, prostate cancer-specific survival, and overall survival. An artificial intelligence ...
SYRACUSE, N.Y., July 08, 2025--(BUSINESS WIRE)--Associated Medical Professionals (A.M.P.) announced today the availability of the ArteraAI Prostate Test, an AI-powered risk stratification tool to help ...
Editor's note: The Larger Trend section has been updated. California-based Artera, a company that develops multimodal AI-based prognostic and predictive cancer tests, has been granted de novo ...
A team of researchers from the Icahn School of Medicine at Mount Sinai and Keck School of Medicine at the University of Southern California (USC) have developed a novel machine-learning framework that ...
A Singapore-based startup has launched a new Artificial Intelligence module, QAi Prostate that analyses whole slide images for accurate prostate cancer diagnosis. An advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback